novel dual-targeting cd19/22 car-t therapy in relapsed all
Published 1 year ago • 116 plays • Length 1:33Download video MP4
Download video MP3
Similar videos
-
4:06
car-t therapy in all: exploring dual-targeting of cd19 & cd22 to overcome resistance
-
3:18
evaluating dual-targeting cd19/22 car-t cells in patients with r/r all
-
2:32
phase i study of cd22-targeted car-t therapy in patients with cd19-negative b-all
-
1:52
opportunities and challenges for dual-targeting car-t therapy in all
-
3:50
the safety and efficacy of auto1/22: a novel co-transduced cd19/22 car-t therapy for r/r all
-
0:45
bispecific car t-cell therapy: combining anti-cd19 and cd22 car t-cells
-
2:19
anbal-cel: updated results from phase i study of novel cd19-targeting car-t therapy
-
3:06
dual-targeting bcma/cd19 car-t therapy in patients with r/r mm
-
1:21
anti-cd22 car t-cell therapy for all: trial update, utility for salvage and cd19 status
-
1:59
efficacy and safety of cd19-targeted car t-cells for relapsed/refractory all
-
2:01
advances in cd22/cd19 car-t sequential therapy
-
2:12
fully human anti-cd19 and cd22 bispecific tandem car-t
-
1:40
overcoming antigen escape following cd19-directed car-t therapy
-
4:17
novel car t-cell therapies for hematological malignancies: exploring new targets
-
1:26
emerging cd19-targeted car-t treatment approaches for nhls
-
1:49
a novel subcutaneous car-t therapy for the treatment of hematological malignancies
-
2:05
novel car-t constructs being explored in myeloma: t-charge platform
-
2:42
dual-targeted anti-cd19/anti-cd20 car t-cells in r/r mcl: insights from a phase i/ii trial
-
2:26
clinical data for cd19-directed car t-cell products in all